: Human gut microbiome is related to different clinical conditions and diseases. Recently several hypotheses have been theorized about a link between gut microbiota and genitourinary disease including urinary tract infections, and benign prostatic hyperplasia. Despite several data, underlying mechanisms still remain unclear. The aim of this review is to report the current state of knowledge in relation to urinary tract infections, benign prostatic hyperplasia and intestinal microbiota with a focus on its role in the development of disease and the underlying pathophysiologic mechanisms.

Intestinal microbiota, intestinal permeability and the urogenital tract: is there a pathophysiological link? / Priadko, K; Romano, L; Olivieri, S; Romeo, M; Barone, B; Sciorio, C; Spirito, L; Morelli, M; Crocetto, F; Arcaniolo, D; Mirone, V; Romano, M; Napolitano, L. - In: JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. - ISSN 0867-5910. - 73:5(2022), pp. 575-585. [10.26402/jpp.2022.5.01]

Intestinal microbiota, intestinal permeability and the urogenital tract: is there a pathophysiological link?

Romano, L;Olivieri, S;Barone, B;Crocetto, F;Arcaniolo, D;Mirone, V;Napolitano, L
2022

Abstract

: Human gut microbiome is related to different clinical conditions and diseases. Recently several hypotheses have been theorized about a link between gut microbiota and genitourinary disease including urinary tract infections, and benign prostatic hyperplasia. Despite several data, underlying mechanisms still remain unclear. The aim of this review is to report the current state of knowledge in relation to urinary tract infections, benign prostatic hyperplasia and intestinal microbiota with a focus on its role in the development of disease and the underlying pathophysiologic mechanisms.
2022
Intestinal microbiota, intestinal permeability and the urogenital tract: is there a pathophysiological link? / Priadko, K; Romano, L; Olivieri, S; Romeo, M; Barone, B; Sciorio, C; Spirito, L; Morelli, M; Crocetto, F; Arcaniolo, D; Mirone, V; Romano, M; Napolitano, L. - In: JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. - ISSN 0867-5910. - 73:5(2022), pp. 575-585. [10.26402/jpp.2022.5.01]
File in questo prodotto:
File Dimensione Formato  
jpp.2022.5.01.pdf

solo utenti autorizzati

Tipologia: Documento in Pre-print
Licenza: Accesso privato/ristretto
Dimensione 590.39 kB
Formato Adobe PDF
590.39 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/919948
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 14
social impact